In recent years, the popularity of medications like Ozempic, Wegovy, and Mounjaro has surged, especially as they offer potential solutions to long-standing issues like obesity as well as diabetes. While these medications have garnered attention for their effectiveness, they have also raised questions about their safety, long-term use, and potential side effects. This blog post delves into the full story of Ozempic, Wegovy, and Mounjaro, exploring what they are, how they work, the potential risks, and what you need to know before considering them as a treatment option.
This has been written with information taken from the Wealth of Health podcast episode ‘Ozempic, Wegovy and Mounjaro What You NEED To Know’.
What Are Ozempic, Wegovy, and Mounjaro?
Ozempic, Wegovy, and Mounjaro are all injectable medications that have been approved for use in managing diabetes and obesity. While they all belong to a class of drugs known as GLP-1 receptor agonists, they have distinct uses and target different patient needs.
- Ozempic (semaglutide) is primarily used for managing type 2 diabetes. It helps control blood sugar levels and has also been shown to assist with weight loss in some patients. Ozempic works by mimicking the effects of a natural hormone in the body that regulates blood sugar and appetite.
- Wegovy (semaglutide) is similar to Ozempic but is approved specifically for weight loss in adults who are either overweight or obese. Wegovy helps people lose weight by reducing hunger and increasing feelings of fullness, which can lead to decreased calorie intake.
- Mounjaro (tirzepatide) is another GLP-1 receptor agonist that has recently been approved for type 2 diabetes management. It works by targeting two hormones, GLP-1 and GIP, which help regulate blood sugar levels and appetite. Mounjaro has also shown promising results in helping patients lose weight, making it an appealing option for those dealing with both obesity and diabetes.
How Do These Medications Work?
The key to understanding the effectiveness of Ozempic, Wegovy, and Mounjaro lies in their mechanism of action. These medications function by activating the GLP-1 receptor in the body, a hormone that plays a crucial role in regulating blood sugar and appetite.
- Blood Sugar Regulation: GLP-1 helps control blood sugar levels by stimulating insulin production, inhibiting glucagon release, and slowing gastric emptying. This results in better control over blood sugar levels, which is essential for people with type 2 diabetes.
- Appetite Suppression: GLP-1 also impacts the hypothalamus, the part of the brain that regulates appetite. By acting on this part of the brain, these medications help reduce hunger and increase feelings of fullness. As a result, patients may eat less, which leads to weight loss over time.
In the case of Mounjaro, the addition of GIP (glucose-dependent insulinotropic peptide) gives it an edge by working on two different hormones, potentially enhancing its effects on blood sugar control and weight loss.
Pre-Checks and Restrictions
Before being prescribed any of these medications, patients typically undergo a few preliminary checks. These medications are not suitable for everyone, and there are some restrictions that patients must be aware of.
For example, family history plays a role in determining eligibility. There is a theoretical risk of a rare type of thyroid cancer associated with these medications, particularly in individuals with a family history of this condition. In addition, pregnant women should avoid using these medications due to potential risks to the developing foetus.
Before starting treatment, patients may undergo routine blood tests to assess kidney and liver function. These tests help ensure that the patient’s organs are functioning normally before starting the medication.
Are These Medications Lifelong Treatments?
One of the questions surrounding these drugs is whether they need to be taken for the rest of a person’s life. Initially, studies on these medications suggested that they should only be used for two years. However, as time has passed, doctors have realised that for many patients, weight loss and appetite control may not be sustainable without ongoing use of the medication.
Stopping the medication often leads to a rebound effect, where individuals regain the weight they lost. This is because their appetite returns to normal, and they may slip back into old eating habits. As a result, many patients may need to continue taking the medication long-term to maintain their weight loss and blood sugar control.
However, this raises an important question: should people remain on these medications indefinitely? As the discussion around these drugs continues to evolve, some experts argue that the long-term side effects are still not fully understood. While there is evidence to suggest potential benefits such as reduced cardiovascular risk and even potential benefits for brain health (such as a reduction in Alzheimer’s risk), the long-term implications of these medications remain unclear.
Costs of Ozempic, Wegovy, and Mounjaro
The financial cost of these medications is an important consideration for many people. In the UK, the price of these medications is around £150 per month. In the United States, the cost can be significantly higher, with some reports indicating prices as much as several hundred dollars per month. The discrepancy in pricing between countries is part of a larger conversation about the healthcare system, pricing transparency, and accessibility to essential medications.
The debate over the high cost of these medications has become especially heated in the U.S., where discussions about whether to prescribe these drugs to obese children or adolescents have taken centre stage. In some cases, there has been controversy around whether these medications should be available for lifelong use in children, especially as a preventive measure against diseases like diabetes.
What Are the Side Effects?
Like all medications, Ozempic, Wegovy, and Mounjaro come with potential side effects. Some of the most common side effects include:
- Nausea: Around 20% of patients experience nausea when taking these medications. For some, this nausea can progress to vomiting (around 5-10% of patients). These side effects typically subside as the body adjusts to the medication.
- Diarrhoea: Another common side effect is diarrhoea, affecting around 15-20% of users. This can also improve over time as the body becomes accustomed to the drug.
These side effects are often dose-dependent, meaning that starting on a low dose and gradually increasing it can help reduce the severity of these reactions. It’s important to work closely with a healthcare provider to find the right dose and to monitor any adverse effects.
While the common side effects are generally manageable, there are some rarer but more serious risks to be aware of:
- Gastroparesis (Delayed Stomach Emptying): These medications can slow down the motility of the gut, and in very rare cases, they can cause gastric paralysis, where the stomach essentially stops moving. This is a serious condition that requires immediate medical attention.
- Pancreatitis: Another rare side effect is pancreatitis, or inflammation of the pancreas. This condition can be life-threatening and requires prompt medical treatment. While pancreatitis is more common in individuals with obesity, the medication may contribute to its development in susceptible individuals.
- Gallstones: These medications can increase the likelihood of developing gallstones, which are more common in people who are overweight, especially women. Gallstones can lead to further complications, such as pancreatitis.
Mental Health Effects
There has been ongoing research into the impact of these medications on mental health. Some studies suggest that GLP-1 receptor agonists may be linked to mood changes, including depression. However, other studies argue that these changes may not be directly caused by the medications, but rather may be the result of other underlying factors such as pre-existing depression or the emotional stress of managing obesity or diabetes.
As with any medication that affects the brain and body’s regulatory systems, it is crucial to monitor mental health closely when starting treatment with Ozempic, Wegovy, or Mounjaro. Patients should have open discussions with their healthcare provider about any changes in mood or behavior and seek support as needed.
Should You Consider These Medications?
When considering whether to use Ozempic, Wegovy, or Mounjaro, it’s essential to weigh the potential benefits against the risks. These medications can be highly effective for controlling blood sugar and aiding weight loss, particularly for individuals with obesity or type 2 diabetes. However, they come with significant costs and potential side effects, some of which can be serious.
The decision to start treatment should be made in close consultation with a healthcare provider. For some individuals, these medications offer a valuable tool for managing chronic conditions and improving overall health. For others, lifestyle changes such as diet and exercise may be sufficient.
Ozempic, Wegovy, and Mounjaro are revolutionising the way doctors and patients approach weight loss and diabetes management. They offer promising results for people struggling with obesity and diabetes, but they are not without risks. Before starting treatment, it’s important to discuss your medical history, undergo necessary tests, and weigh the pros and cons with your healthcare provider.
While these medications can offer significant benefits, especially in terms of blood sugar control and weight loss, they are not a one-size-fits-all solution. As the research on their long-term effects continues, patients and healthcare providers will need to stay informed about the evolving landscape of treatment options.
Ultimately, whether these medications are the right choice depends on individual health goals, risk factors, and the guidance of a trusted medical professional.
A Preventative Health Approach
Before considering medications like Ozempic, Wegovy, or Mounjaro for weight management, undergoing a comprehensive preventative health assessment can provide valuable insights into an individual’s overall health. These assessments, which often include blood tests, liver and kidney function tests, and cardiovascular risk evaluations, can help identify underlying conditions such as diabetes, thyroid disorders, or metabolic syndrome that may influence treatment decisions. Additionally, given the potential for serious side effects, including pancreatitis and gallbladder disease, screening for pre-existing risk factors can help determine whether these medications are a safe and suitable option. By understanding their health risks and predispositions, individuals can make more informed choices about weight management strategies, including whether lifestyle modifications or alternative treatments might be preferable before starting long-term medication.
Echelon Health Offers World Leading Health Assessments
At Echelon Health, we are proud to offer a Platinum Assessment that is highly effective in detecting a wide array of illnesses. In fact, we can identify up to 92% and 95% of the preventable causes of death in men and women, respectively.
If you have any questions contact our team to speak with our Head of Private Clients or check out our health assessment packages for more information on the assessments we can offer you!
Did you enjoy this blog? If so, we think you’d enjoy the Wealth of Health podcast. Find us on YouTube and Spotify
Further Reading
https://www.diabetesdaily.com/blog/ozempic-and-side-effects-nausea-diarrhea-vomiting-710240/
https://www.advisory.com/daily-briefing/2023/08/21/weight-loss-drug-cost
